Nuvectis Pharma, Inc. (NVCT) Net income 2021–2025
Nuvectis Pharma, Inc. (NVCT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.4MFY2025 · since FY2021: -$12.9M → -$26.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.4M | -39.2% |
| FY2024 | -$19.0M | +14.6% |
| FY2023 | -$22.3M | -16.6% |
| FY2022 | -$19.1M | -48.1% |
| FY2021 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice